Barclays Maintains an 'Equalweight' on Calumet Specialty Products Partners (CLMT): Expect Distribution Growth To Modestly Improve
Tweet Send to a Friend
Barclays maintains an 'Equalweight' on Calumet Specialty Products Partners (NASDAQ: CLMT), PT $22.
Barclays analyst says, "Specialty margins and volumes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "Specialty margins and volumes ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
